MetaCap

Tvardi Therapeutics Insider Trades

NASDAQ: TVRDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.03-0.05 (-4.63%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Tvardi Therapeutics insider activity

No Tvardi Therapeutics insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Tweardy Samuel David (10% Owner) reporting a transaction in 315,658 shares on Jul 7, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TVRD's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

TVRD insider transactions

Tvardi Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Jul 7, 2025Tweardy Samuel David10% Ownerother315,658—Form 4
Jul 7, 2025Tweardy Samuel David10% Ownerother315,658—Form 4
Apr 15, 2025Wirk ShaheenDirectorother263,164—Form 4
Apr 15, 2025Wirk ShaheenDirectorother176,030—Form 4
Apr 15, 2025Wirk ShaheenDirectorAward4,191—Form 4
Apr 15, 2025HALL WALLACE L JRDirectorother202,044—Form 4
Apr 15, 2025HALL WALLACE L JRDirectorother44,712—Form 4
Apr 15, 2025Wirk ShaheenDirectorAward263,164—Form 4
Apr 15, 2025Wirk ShaheenDirectorAward176,030—Form 4
Apr 15, 2025HALL WALLACE L JRDirectorAward202,044—Form 4
Apr 15, 2025HALL WALLACE L JRDirectorAward44,712—Form 4
Feb 28, 2025Posner ChristopherPRESIDENT AND CEOSale583$2.77KForm 4
Feb 28, 2025Terrillion ScottSEC'Y; CHIEF COMPLIANCE & G.C.Sale163$775.88Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related